close
MENU
Tech & Innovation
5 mins to read

Medtech startup Alimetry raises US$18m to diagnose gut disorders

The money raised will continue its push into US hospitals.

Gastric Alimetry’s is the startup’s main product.

Medtech startup Alimetry has raised an oversubscribed US$18 million ($29.9m) second tranche of Series A funding that will help accelerate expansion in the United States.

The round was led by Kiwi VC firm GD1, with participation from the American Gastroenterological Association GI Opportunity Fund,

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Fiona Rotherham Fri, 25 Oct 2024
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Medtech startup Alimetry raises US$18m to diagnose gut disorders
Tech & Innovation,
106442
true